Amgen sells its Turkish manufacturing arm for $135M
Pharma giant Amgen has decided to sell off its Turkish manufacturing arm for nine figures.
The Eczacıbaşı Group has acquired Gensenta from the California-based pharma. The deal will see Eczacıbaşı pay $135 million for a 99.96% stake in the company. The purchase of Gensenta will be finalized after it gets approval from the Turkish Competition Authority.
According to Eczacıbaşı, Amgen Turkey will continue to keep its operations running and serve its customers.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.